Clinical Trial Update: Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of rozanolixizumab in adult Chinese participants with generalized myasthenia gravis is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Rozanolixizumab

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Myasthenia Gravis | Phase 4 | Status: RECRUITING